Board of Radiation & Isotope Technologies
BRIT is an independent unit of India's Department of Atomic Energy producing radiopharmaceuticals, sealed radiation sources, gamma processing services, and radiation equipment for healthcare, agriculture, research, and industrial customers across India and select international markets.
- Company typePrivate
- Founded1989
- HeadquartersMumbai, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Board of Radiation & Isotope Technologies does
Board of Radiation & Isotope Technology (BRIT) is an independent unit of India's Department of Atomic Energy (DAE), headquartered within the BARC complex in Navi Mumbai. Established in 1989, BRIT is the premier Indian government organization producing radiation and isotope-based products and services across four primary verticals: healthcare, agriculture, research, and industry. Its core product portfolio includes radiopharmaceuticals (PET, SPECT, and therapeutic formulations such as I-131, Lu-177 PSMA-617, Lu-177 DOTA-TATE), sealed radiation sources (cobalt-60 teletherapy, brachytherapy, radiography, and irradiator sources), radiation technology equipment (gamma chambers, blood irradiators, radiography cameras), radiochemicals, radioimmunoassay kits, labelled compounds, dosimeters, and biological indicators.
BRIT's production infrastructure is anchored by the RAPPCOF facility in Kota — India's only site with a complete cobalt-60 sealed source production cycle from reactor to finished product — the ISOMED gamma radiation processing plant (recently upgraded as ISOMED 2.0, commercial from May 2025), and the Medical Cyclotron Facility (Cyclone-30) at Kolkata commissioned in 2019. The organization operates six regional centers (Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, Kota) providing nationwide distribution of time-sensitive radiopharmaceuticals and on-site customer support, alongside an online ordering portal and the BRIT Bandhu mobile application.
BRIT's business model is hybrid: it sells radiopharmaceuticals, sealed sources, and radiation equipment as one-time purchases to hospitals, cancer centers, blood banks, research institutions, and industrial customers; and provides fee-based services including medical product sterilization, food irradiation, calibration, dosimetry, and consultancy. All sales require AERB regulatory authorization through the eLORA system, creating a regulatory moat that effectively makes BRIT the sole compliant domestic supplier. The organization holds international certifications (ISO/ASTM 51205, ANSI N433.1, ISO-3999, ISO 11137, US Pharmacopoeia) and participates in IAEA coordinated research programs. Customers include Tata Memorial Centre, Dr. Bhubaneswar Borooah Cancer Institute, food processors, and 1,500+ institutional buyers across India, with cobalt-60 sealed sources also exported internationally.
Board of Radiation & Isotope Technologies firmographics
Firmographics- Name
- Board of Radiation & Isotope Technologies
- Legal name
- Board of Radiation & Isotope Technology
- Website
- https://britatom.gov.in
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- BRIT is an independent unit of India's Department of Atomic Energy producing radiopharmaceuticals, sealed radiation sources, gamma processing services, and radiation equipment for healthcare, agriculture, research, and industrial customers across India and select international markets.
- Ownership category
- akta.pro rank
Board of Radiation & Isotope Technologies industry classification
Industry- Product category
- Radiopharmaceuticals and Radiation Technology Products
- NAICS
- Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516), Testing Laboratories and Services (54138)
- SIC
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA)
- akta.pro secondary industries
- Sealed Source Manufacturing, Encapsulation & Recycling/Take-Back (Source lifecycle management) (EUAKAIAI), Radiation Processing & Sterilization Services (Medical device sterilization, food irradiation, materials modification) (EUAKAIAG), Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology) (EUAKAIAD), Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs) (EUAKAIAH), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ), Radiation Detection Instruments & Systems (Portal monitors, spectrometers, contamination monitors) (EUAKAIAK), Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD), Radiopharmaceutical & Nuclear Medicine Distributors (HLAIAJAI)
Keywords
Where Board of Radiation & Isotope Technologies is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices7 records
Markets served
Board of Radiation & Isotope Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- Radiopharmaceutical Products: Sale of radiopharmaceuticals including PET products, SPECT products, therapeutic radiopharmaceuticals, and radiochemicals to hospitals and medical institutions
- Sealed Radiation Sources: Manufacturing and sale of sealed radiation sources including cobalt teletherapy sources, irradiator sources, and radiography sources
- Radiation Equipment: Sale of radiation technology equipment including gamma chambers, blood irradiators, and radiography cameras
- Service Operations: Sterilization of medical products, radiation processing plant services, radioanalytical laboratory services, isotope application services, EB processing services, calibration services, and dosimetry services
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Government/military |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
Board of Radiation & Isotope Technologies product offering
Product offeringCore offering
Board of Radiation & Isotope Technology (BRIT) manufactures and supplies radiopharmaceuticals (PET, SPECT, therapeutic, radiochemical), sealed radiation sources (cobalt-60 teletherapy, irradiator, radiography, brachytherapy), and radiation technology equipment (gamma chambers, blood irradiators, radiography cameras). The organization also provides radiation-based services including medical product sterilization, radiation processing, dosimetry, calibration, and consultancy to healthcare, agriculture, research, and industrial customers across India.
Product overview
BRIT (Board of Radiation & Isotope Technology) is an independent unit of India's Department of Atomic Energy providing a comprehensive portfolio of radiation and isotope-based products and services for healthcare, agriculture, research, and industry applications. The company's offerings include: (1) Radiopharmaceuticals for PET and SPECT imaging and therapeutic applications; (2) Radio Immunoassay Kits for hormone testing; (3) Labelled Compounds (Tritium, Carbon-14, Sulphur-35) for research; (4) Sealed Sources including Cobalt Teletherapy, Irradiator, Radiography, and Brachytherapy sources; (5) Radiation Technology Equipment including Gamma Chambers (GC 5000, GC 1200), Blood Irradiators (BI 2000), and Radiography Cameras (ROLI-2, ROLI-3, COCAM-120); (6) Dosimetry products including Ceric-Cerous Dosimeters and Biological Indicators; (7) Low Level Check Sources; and (8) Various services including medical product sterilization, radiation processing, calibration, and consultancy. The company operates regional centers in Mumbai, Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, and Kota.
Differentiator
Problem solved
Functional benefit
Brands
- BRIT Bandhu: Mobile application for BRIT services and information
- ISOMED 2.0
- RAPPCOF (RAPS Cobalt Facility)
- Cyclone-30
Products and services
- Radiopharmaceuticals
Quantifiable outcome
- 1500+ customers served across India
- +3 more outcomes
Companies that use Board of Radiation & Isotope Technologies
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Board of Radiation & Isotope Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Board of Radiation & Isotope Technologies partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered minor and core.
- District Project Livelihood College Society, DantewadaminorMoU for livelihood training and skill development programs related to radiation technology applications
- Sri Varsha Food Products India Pvt. LtdminorMoU for food processing and radiation sterilization services
- Fanidhar Mega Food Park Pvt. LtdminorMoU for food irradiation and preservation services at mega food park facility
- HK Food ParkminorMoU for food processing radiation services
- Tarson Products Limited, KolkataminorMoU for Radiation Processing Plant (RPP) services
- Q-Line HealthcareminorMoU for healthcare sector radiation services
- Green RadminorMoU for radiation technology services in green/radiation applications
- Microwin Sterisolutions Pvt. LtdminorMoU for sterilization solutions and services
- Vishvesh Agromed Pvt. Ltd, MaharashtraminorMoU for agricultural and medical radiation applications
- Hon. Balasaheb Thackeray Haridra Research and Training CenterminorMoU for research and training in radiation technology applications
- Poly Medicure LtdminorMoU for medical equipment sterilization services
- International Atomic Energy Agency (IAEA)coreParticipation in IAEA programs including CRP projects, international conferences on radiation science and technology, and technology transfer initiatives
- Variable Energy Cyclotron Centre (VECC), KolkatacoreHosting of Medical Cyclotron Facility (Cyclone-30) at VECC premises for production of PET and SPECT radioisotopes for Eastern India
- Bhabha Atomic Research Centre (BARC)coreBRIT operates within BARC complex and receives technical support and isotope production from research reactors at BARC
- Cellular and Molecular Biology Centre (CCMB), HyderabadcoreRegional Centre Hyderabad is located at CCMB campus for collaboration in molecular biology and biotechnology research
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Board of Radiation & Isotope Technologies competitors and assessment
Company assessmentBroad incumbents
- Australian Nuclear Science and Technology Organisation (ANSTO): Australia's national nuclear science and technology agency, operating the OPAL reactor for Mo-99 production and producing radiopharmaceuticals, sealed sources, and irradiation services. Closest structural peer to BRIT as a government-operated multi-product nuclear technology organization with healthcare, research, and industrial mandates.
- Lantheus Holdings: US-based radiopharmaceutical company focused on diagnostic imaging agents including SPECT and PET products. Comparable to BRIT's diagnostic radiopharmaceutical segment serving hospitals and nuclear medicine departments.
- China Isotope & Radiation Corporation (CIRC): State-owned Chinese nuclear technology enterprise producing radiopharmaceuticals, radioactive sources, and irradiation services. Highly comparable to BRIT as a vertically integrated government-affiliated radiation technology organization serving healthcare, industry, and research within a domestic market.
- Nordion ( Sotera Health subsidiary): Canadian-based global supplier of Cobalt-60 sealed sources, medical isotopes, and sterilization services. Directly comparable to BRIT's RAPPCOF cobalt source operations and ISOMED gamma sterilization, serving teletherapy and industrial radiography markets globally.
Direct peers
- Curium Pharma: Global nuclear medicine company producing SPECT, PET, and therapeutic radiopharmaceuticals (including Lu-177 products). Directly comparable to BRIT's radiopharmaceutical portfolio for diagnostic imaging and cancer therapy across healthcare customers.
- Institute of Radioelements (IRE): Belgian producer of radioisotopes (Mo-99, I-131, Lu-177) for medical and industrial applications, including sealed source manufacturing. Comparable to BRIT in Mo-99/Tc-99m generator production, therapeutic radiopharmaceuticals, and sealed radiation source manufacturing for cancer treatment and industrial radiography.
- Eckert & Ziegler Radiopharma: German-based manufacturer of radioisotopes, radiopharmaceuticals, and radiation technology components. Comparable to BRIT's portfolio of sealed sources, calibrated radioactive reference sources, and radiopharmaceutical precursors for medical and industrial use.
- POLATOM (National Centre for Nuclear Research): Polish national center producing radiopharmaceuticals, radioactive sources, and labelled compounds for research. Closely comparable to BRIT as a national nuclear research institute with radiopharma, sealed source, and labelled compound product lines.
Emerging players
- SHINE Medical Technologies: US-based medical isotope producer developing Mo-99 production and therapeutic radiopharmaceuticals. Comparable to BRIT's medical radioisotope production activities for diagnostic nuclear medicine supply.
- Telix Pharmaceuticals: Commercial-stage radiopharma company developing Ga-68 and Lu-177 based theranostic agents for prostate, kidney, and brain cancers. Comparable to BRIT's emerging Ga-68 PET and Lu-177 PSMA-617 therapeutic portfolio as a focused theranostics competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Board of Radiation & Isotope Technologies social profiles
Digital presenceBoard of Radiation & Isotope Technologies compliance and trust
Trust signalCompliance10 records
Board of Radiation & Isotope Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Board of Radiation & Isotope Technologies leadership team
Management profileNumber of profiles
Profiles10 records
Board of Radiation & Isotope Technologies subsidiaries and ownership
Company hierarchySubsidiaries9 records
Board of Radiation & Isotope Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Board of Radiation & Isotope Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Board of Radiation & Isotope Technologies
What does Board of Radiation & Isotope Technologies do?
Board of Radiation & Isotope Technology (BRIT) manufactures and supplies radiopharmaceuticals (PET, SPECT, therapeutic, radiochemical), sealed radiation sources (cobalt-60 teletherapy, irradiator, radiography, brachytherapy), and radiation technology equipment (gamma chambers, blood irradiators, radiography cameras). The organization also provides radiation-based services including medical product sterilization, radiation processing, dosimetry, calibration, and consultancy to healthcare, agriculture, research, and industrial customers across India.
Is Board of Radiation & Isotope Technologies a public or private company?
Board of Radiation & Isotope Technologies is a private company. It is classified as state government owned and is currently operating.
When was Board of Radiation & Isotope Technologies founded?
Board of Radiation & Isotope Technologies was founded in 1989. It employs 501 to 1,000 people.
Where is Board of Radiation & Isotope Technologies based?
Board of Radiation & Isotope Technologies is headquartered in Mumbai, India, in the Asia region.
How does Board of Radiation & Isotope Technologies make money?
Four revenue lines are on record. Radiopharmaceutical Products are the primary driver. The others are sealed Radiation Sources, radiation Equipment and service Operations.
Who are Board of Radiation & Isotope Technologies's main competitors?
Broad incumbents on record are Australian Nuclear Science and Technology Organisation (ANSTO), Lantheus Holdings, China Isotope & Radiation Corporation (CIRC) and Nordion ( Sotera Health subsidiary). Direct peers are Curium Pharma, Institute of Radioelements (IRE), Eckert & Ziegler Radiopharma and POLATOM (National Centre for Nuclear Research). Emerging players are SHINE Medical Technologies and Telix Pharmaceuticals.
Does Board of Radiation & Isotope Technologies have an API?
No public API is recorded for Board of Radiation & Isotope Technologies.
What industry is Board of Radiation & Isotope Technologies in?
Board of Radiation & Isotope Technologies's product category is Radiopharmaceuticals and Radiation Technology Products. Its primary akta.pro industry code is EUAKAIAA, Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.), with a secondary code of EUAKAIAI, Sealed Source Manufacturing, Encapsulation & Recycling/Take-Back (Source lifecycle management). Its NAICS code is 334517 and its SIC code is 3844.